Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis

被引:106
作者
Ueno, Hideki [1 ]
Shinto, Eiji [1 ]
Shimazaki, Hideyuki [2 ]
Kajiwara, Yoshiki [1 ]
Sueyama, Takahiro [1 ]
Yamamoto, Junji [1 ]
Hase, Kazuo [1 ]
机构
[1] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan
[2] Natl Def Med Coll Hosp, Dept Lab Med, Tokorozawa, Saitama, Japan
关键词
LYMPHOID REACTION; TENASCIN-C; TUMOR; FIBROBLASTS; EXPRESSION; STROMA; ANGIOGENESIS; CARCINOMA; HALLMARKS; CELLS;
D O I
10.1245/s10434-014-4149-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although the essential roles of stromata in tumor development have been recognized, the morphologic classification of desmoplastic reaction (DR) in colorectal cancer (CRC) is unclear. In this study, DRs were histologically classified into three patterns based on the products of activated fibroblasts (i.e., keloid-like collagen and myxoid stroma). The prognostic impact of DRs was evaluated in two independent cohorts of stages 2 and 3 CRC patients: cohort 1 (880 patients) and cohort 2 (474 patients). The association of DR and the local environment was investigated immunohistochemically. In cohort 1, mature DR was shown by 413 patients, intermediate DR by 275 patients, and immature DR by 192 patients. Categorization of DR was significantly associated with tumor location, pT and pN stages, tumor differentiation, venous invasion, tumor budding, and Crohn's-like lymphoid reaction (P a parts per thousand currency sign 0.0001-0.008). Immature DR was relevant to the high incidence of recurrence in the liver, lung, lymph nodes, peritoneum, and locoregional areas (P a parts per thousand currency sign 0.0001-0.002). The 5-year disease-free survival rate was highest in the mature group (87 %), followed by the intermediate group (72 %) and the immature group (49 % (P < 0.0001). In the multivariate analysis, DR showed an impact on survival outcome independent of conventional prognostic factors, including pT and pN stages. These results were similarly observed in cohort 2. Immature DR was associated with normal MutL homologue 1 (MLH1)/MutS homologue 2 (MSH2) immunoreactivity, a smaller number of infiltrating CD8(+) T cells and tumor-associated macrophages, a decreased microvessel count, and positive expression of tenascin-C and fibronectin. The proposed histologic DR categorization directly reflects tumor behavior in a modulating stromal environment and could provide valuable prognostic information for CRC patients.
引用
收藏
页码:1504 / 1512
页数:9
相关论文
共 31 条
  • [1] Keloids: Current concepts of pathogenesis (Review)
    Bran, Gregor M.
    Goessler, Ulrich R.
    Hormann, Karl
    Riedel, Frank
    Sadick, Haneen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (03) : 283 - 293
  • [2] The stroma reaction myofibroblast:: a key player in the control of tumor cell behavior
    Desmoulière, A
    Guyot, C
    Gabbiani, C
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2004, 48 (5-6) : 509 - 517
  • [3] The Pancreas Cancer Microenvironment
    Feig, Christine
    Gopinathan, Aarthi
    Neesse, Albrecht
    Chan, Derek S.
    Cook, Natalie
    Tuveson, David A.
    [J]. CLINICAL CANCER RESEARCH, 2012, 18 (16) : 4266 - 4276
  • [4] INDUCTION OF ANGIOGENESIS DURING THE TRANSITION FROM HYPERPLASIA TO NEOPLASIA
    FOLKMAN, J
    WATSON, K
    INGBER, D
    HANAHAN, D
    [J]. NATURE, 1989, 339 (6219) : 58 - 61
  • [5] GRAHAM DM, 1990, MODERN PATHOL, V3, P332
  • [6] Expression of tenascin-C and its isoforms in the breast
    Guttery, David S.
    Shaw, Jacqueline A.
    Lloyd, Kirsty
    Pringle, J. Howard
    Walker, Rosemary A.
    [J]. CANCER AND METASTASIS REVIEWS, 2010, 29 (04) : 595 - 606
  • [7] Hallmarks of Cancer: The Next Generation
    Hanahan, Douglas
    Weinberg, Robert A.
    [J]. CELL, 2011, 144 (05) : 646 - 674
  • [8] Hanamura N, 1997, INT J CANCER, V73, P10, DOI 10.1002/(SICI)1097-0215(19970926)73:1<10::AID-IJC2>3.0.CO
  • [9] 2-4
  • [10] Intra-tumoural microvessel density in human solid tumours
    Hasan, J
    Byers, R
    Jayson, GC
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1566 - 1577